Irina A Kerle1,2,3, Thomas Gross4, Anja Kögler4

  • 1Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. irina.kerle@nct-dresden.de.

NPJ precision oncology
|January 10, 2025
PubMed
概括

在罕见的瘤中,将广泛的基因组与全外体/基因组 (WES/WGS) 和转录组测序 (TS) 进行比较,发现了类似的治疗建议. 然而,WES/WGS±TS确定了小组遗漏的关键生物标志物,强调了它们的临床价值.